On June 12, New China Life Insurance rose 3.39% in regular trading, trading at HK$50.25/share, with turnover of HK$174 million.

On the news front, the company announced on June 10 that Central Huijin Investment, holding 31.34% of shares, nominated Huang Geng as a non-executive director candidate for the ninth board. Huang Geng currently serves as division head and second-level inspector at the National Financial Regulatory Administration, bringing extensive financial regulatory experience. The proposal awaits shareholder meeting approval and regulatory clearance.

Additionally, CSI index sample adjustments for the CSI 300 and related indices are set to take effect after market close on June 12, drawing institutional attention to non-bank financial allocations. CITIC Securities noted that the insurance sector offers high allocation value, with asset-side recovery expected to drive Q2 profit growth and share price recovery. Huatai Securities indicated that if market conditions remain stable in June, Q2 could become the strongest quarter for insurance industry earnings, with liability-side growth momentum remaining robust.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)